U S Physical Therapy Inc key statistics and ratios
In fiscal 2025, U S Physical Therapy Inc had return on equity of 8.2%, an operating margin of 11.1%, debt equal to 34.1% of equity and a current ratio of 1.01. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 26.5% | 24.1% | 25.2% | 24.5% | 25.0% | 23.7% | 23.0% | 21.9% | 22.4% | 23.3% | 22.3% | 23.7% | 20.3% | 20.1% | 18.5% | 19.2% | 18.7% |
| Operating margin | 14.0% | 15.7% | 13.6% | 15.4% | 14.7% | 15.0% | 14.3% | 13.9% | 13.2% | 13.3% | 14.0% | 12.4% | 14.3% | 10.3% | 8.4% | 9.4% | 11.1% | 9.4% |
| Net margin | 5.8% | 7.4% | 9.1% | 7.2% | 4.8% | 6.3% | 6.2% | 5.8% | 5.4% | 7.7% | 8.3% | 8.3% | 8.2% | 5.8% | 4.7% | 4.7% | 5.1% | 4.0% |
| Free-cash-flow margin | 13.4% | 12.7% | 12.7% | 14.0% | 15.2% | 13.1% | 9.4% | 12.0% | 11.9% | 14.5% | 10.8% | 21.8% | 13.8% | 9.1% | 12.0% | 9.8% | 7.8% | 7.9% |
| Return on equity | 12.8% | 15.9% | 19.9% | 16.0% | 10.4% | 13.9% | 13.0% | 11.5% | 11.3% | 16.6% | 17.6% | 13.6% | 14.3% | 10.5% | 7.1% | 6.5% | 8.2% | 7.0% |
| Return on assets | — | 11.1% | 13.8% | 10.7% | 6.4% | 8.2% | 7.5% | 6.3% | 5.8% | 8.1% | 7.5% | 5.7% | 6.1% | 4.0% | 3.0% | 2.9% | 3.3% | 2.6% |
| Asset turnover | — | 1.50 | 1.52 | 1.49 | 1.33 | 1.30 | 1.21 | 1.09 | 1.08 | 1.05 | 0.90 | 0.69 | 0.74 | 0.69 | 0.65 | 0.62 | 0.66 | 0.66 |
| Current ratio | — | 2.76 | 2.80 | 2.78 | 2.14 | 2.15 | 3.17 | 2.68 | 1.95 | 1.89 | 1.41 | 0.94 | 1.14 | 1.30 | 2.28 | 1.18 | 1.01 | 1.27 |
| Debt to equity | 0.0% | 5.5% | 22.6% | 15.4% | 32.3% | 24.3% | 28.7% | 27.6% | 29.7% | 18.4% | 21.3% | 7.8% | 40.1% | 58.2% | 30.8% | 31.4% | 34.1% | 49.0% |
| Interest cover (operating income ÷ interest) | 80.3x | 140.6x | 63.4x | 69.0x | 72.1x | 6.1x | 6.5x | 4.3x | 2.6x | 29.5x | 32.4x | — | — | — | — | — | — | — |
| Effective tax rate | 28.4% | 26.4% | 26.7% | 29.6% | 32.0% | 34.0% | 34.0% | 31.1% | 17.9% | 18.9% | 19.2% | 19.9% | 20.9% | 21.9% | 24.6% | 24.3% | 25.5% | 26.1% |
| SG&A as % of revenue | — | — | — | — | 9.8% | 10.0% | 9.4% | 9.1% | 8.7% | 9.1% | 9.3% | 9.9% | 9.4% | 8.3% | 8.6% | 8.7% | 8.9% | 9.0% |
| Capital spending as % of revenue | 1.9% | 1.7% | 1.4% | 1.7% | 1.8% | 1.7% | 1.9% | 2.3% | 1.7% | 1.6% | 2.1% | 1.8% | 1.7% | 1.5% | 1.5% | 1.4% | 1.8% | 2.3% |
| Free cash flow ÷ net income | 230.0% | 171.6% | 140.3% | 195.3% | 315.6% | 209.2% | 151.6% | 208.2% | 222.1% | 188.7% | 130.5% | 262.4% | 167.0% | 156.4% | 257.4% | 209.2% | 154.1% | 198.8% |
| Dividends ÷ net income | — | — | 18.1% | 50.3% | 38.0% | 30.7% | 36.1% | 41.4% | 45.2% | 33.4% | 36.4% | 11.7% | 46.0% | 66.3% | 85.4% | 84.5% | 69.1% | — |
| Dividends and buybacks ÷ free cash flow | 20.6% | 5.2% | 28.7% | 25.8% | 12.0% | 14.7% | 23.8% | 19.9% | 20.4% | 17.7% | 27.9% | 4.5% | 27.5% | 42.4% | 33.2% | 40.4% | 54.0% | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 17.3% | 18.0% | 16.9% | 21.1% | 18.7% | 19.8% | 16.5% | 19.6% |
| Operating margin | 7.6% | 10.9% | 10.7% | 12.6% | 12.8% | 8.3% | 6.3% | 10.3% |
| Net margin | 3.9% | 5.1% | 5.4% | 6.3% | 6.7% | 2.0% | 2.5% | 4.6% |
| Free-cash-flow margin | 11.7% | 9.4% | −3.9% | 16.0% | 7.9% | 10.4% | −0.8% | 13.6% |
| Current ratio | 1.78 | 1.18 | 1.17 | 1.18 | 1.20 | 1.01 | 1.19 | 1.27 |
| Debt to equity | 29.5% | 31.4% | 33.5% | 32.0% | 31.8% | 34.1% | 43.7% | 49.0% |
| SG&A as % of revenue | 8.6% | 8.6% | 8.8% | 8.9% | 8.8% | 8.9% | 9.2% | 8.9% |
Financial health
- Short-term assets cover short-term liabilities $140m of assets due within a year against $110m of liabilities due within a year.
- Short-term assets cover long-term liabilities $140m short-term assets against $372m of longer-dated liabilities.
- More cash than debt $25m of cash against $220m of debt.
- Debt below 40% of shareholders' equity Debt is 49% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 40% to 49% over five years.
- A year's operating cash flow covers at least 20% of debt $83m of operating cash flow against $220m of debt.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Moderate moat
How hard U S Physical Therapy's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 6 / 20
Net income has been a median 4.8% of total assets over 10 years.
- Pricing power 8 / 20
Gross margin has been a median 21.1%, moving by 2.1 percentage points (standard deviation) across 10 years.
- Durability 11 / 20
Operating margin has been a median 11.8%; its worst year was 7.0%.
- Cash conversion 16 / 20
Free cash flow was positive in 10 of 10 years, at a median 11.0% of revenue.
- Discipline 11 / 20
The diluted share count rose 17.7% over five years; stock-based pay has been a median 1.3% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (51 before it).
Compare with peers
- Corvel Corp statistics
- Innovage Holding Corp. statistics
- Pennant Group, Inc. statistics
- Starling Oncology, Inc. statistics
- Guardant Health, Inc. statistics
Head to head: CRVL vs USPHINNV vs USPHPNTG vs USPHSTLN vs USPH
More: Health Care Services stocks compared, Health Care sector, rankings of US companies